Identification of a novel virulence factor in recombinant pneumonia virus of mice

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9490-9501

  Krempl, Christine D ^a,b,c   Wnekowicz, Anna ^a   Lamirande, Elaine W ^b   Nayebagha, Giw ^a   Collins, Peter L ^b   Buchholz, Ursula J ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE DELETION; GENE SEQUENCE; GENETIC ENGINEERING; MOUSE; NONHUMAN; PNEUMONIA; PNEUMOVIRINAE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CELL LINE; CRICETINAE; GENE DELETION; GENES, REPORTER; GENETIC ENGINEERING; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED BALB C; MURINE PNEUMONIA VIRUS; RECOMBINATION, GENETIC; SEQUENCE DELETION; SURVIVAL ANALYSIS; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRULENCE FACTORS; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; MURINAE; MURINE PNEUMONIA VIRUS; MUS; POTATO VIRUS M;

EID: 34548148404     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00364-07     Document Type: Article

References (47)

1. Alff, P. J., I. N. Gavrilovskaya, E. Gorbunova, K. Endriss, Y. Chong, E. Geimonen, N. Sen, N. C. Reich, and E. R. Mackow. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 80:9676-9686.
2. Barr, J., P. Chambers, P. Harriott, C. R. Pringle, and A. J. Easton. 1994. Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J. Virol. 68:5330-5334.
3. Bermingham, A., and P. L. Collins. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. USA 96:11259-11264.
4. Biacchesi, S., Q. N. Pham, M. H. Skiadopoulos, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J. Virol. 79:12608-12613.
5. Biacchesi, S., M. H. Skiadopoulos, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2004. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321:247-259.
6. Biacchesi, S., M. H. Skiadopoulos, L. Yang, E. W. Lamirande, K. C. Tran, B. R. Murphy, P. L. Collins, and U. J. Buchholz. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887.
7. Bossert, B., and K. K. Conzelmann. 2002. Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76:4287-4293.
8. Buchholz, U. J., S. Biacchesi, Q. N. Pham, K. C. Tran, L. Yang, C. L. Luongo, M. H. Skiadopoulos, B. R. Murphy, and P. L. Collins. 2005. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J. Virol. 79:6588-6597.
9. Buchholz, U. J., S. Finke, and K. K. Conzelmann. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
10. Collins, P. L., M. G. Hill, E. Camargo, H. Grosfeld, R. M. Chanock, and B. R. Murphy. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA 92:11563-11567.
11. Collins, P. L., M. G. Hill, J. Cristina, and H. Grosfeld. 1996. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl. Acad. Sci. USA 93:81-85.
12. Cook, P. M., R. P. Eglin, and A. J. Easton. 1998. Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization. J. Gen. Virol. 79:2411-2417.
13. Domachowske, J. B., C. A. Bonville, A. J. Easton, and H. F. Rosenberg. 2002. Differential expression of proinflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infections. J. Infect. Dis. 186:8-14.
14. Durbin, A. P., S. L. Hall, J. W. Siew, S. S. Whitehead, P. L. Collins, and B. R. Murphy. 1997. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235:323-332.
15. Easton, A. J., J. B. Domachowske, and H. F. Rosenberg. 2004. Animal pneumoviruses: molecular genetics and pathogenesis. Clin. Microbiol. Rev. 17:390-412.
16. Eaton, M. D., and W. van Herick. 1944. Demonstration in cotton rats and rabbits of a latent virus related to pneumonia virus of mice. Proc. Soc. Exp. Biol. Med. 54:89-92.
17. Elroy-Stein, O., T. R. Fuerst, and B. Moss. 1989. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. USA 86:6126-6130.
18. Fearns, R., and P. L. Collins. 1999. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J. Virol. 73:5852-5864.
19. Hendricks, D. A., K. McIntosh, and J. L. Patterson. 1988. Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J. Virol. 62:2228-2233.
20. Horsfall, F. L., and E. C. Curnen. 1946. Studies on pneumonia virus of mice. II. Immunological evidence of latent infection with the virus in numerous mammalian species. J. Exp. Med. 83:43-64.
21. Horsfall, F. L., and R. G. Hahn. 1940. A latent virus in normal mice capable of producing pneumonia in its natural host. J. Exp. Med. 71:391-408.
22. Horsfall, F. L., and R. G. Hahn. 1939. A pneumonia virus of Swiss mice. Proc. Soc. Exp. Biol. Med. 40:684-686.
23. Krempl, C. D., and P. L. Collins. 2004. Reevaluation of the virulence of prototypic strain 15 of pneumonia virus of mice. J. Virol. 78:13362-13365.
24. Krempl, C. D., E. W. Lamirande, and P. L. Collins. 2005. Complete sequence of the RNA genome of pneumonia virus of mice (PVM). Virus Genes 30:237-249.
25. Ling, R., and C. R. Pringle. 1989. Polypeptides of pneumonia virus of mice. I. Immunological cross-reactions and post-translational modifications. J. Gen. Virol. 70:1427-1440.
26. Ling, R., and C. R. Pringle. 1989. Polypeptides of pneumonia virus of mice. II. Characterization of the glycoproteins. J. Gen. Virol. 70:1441-1452.
27. Lo, M. S., R. M. Brazas, and M. J. Holtzman. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79:9315-9319.
28. Miyata, H., M. Kishikawa, H. Kondo, C. Kai, Y. Watanabe, K. Ohsawa, and H. Sato. 1995. New isolates of pneumonia virus of mice (PVM) from Japanese rat colonies and their characterization. Exp. Anim. 44:95-104.
29. Moore, M. L., and R. S. Peebles, Jr. 2006. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol. Ther. 112:405-424.
30. Naylor, C. J., P. A. Brown, N. Edworthy, R. Ling, R. C. Jones, C. E. Savage, and A. J. Easton. 2004. Development of a reverse-genetics system for Avian pneumovirus demonstrates that the small hydrophobic (SH) and attachment (G) genes are not essential for virus viability. J. Gen. Virol. 85:3219-3227.
31. Pearson, H. E., and M. D. Eaton. 1940. A virus pneumonia of Syrian hamsters. Proc. Soc. Exp. Biol. Med. 45:677-679.
32. Polack, F. P., P. M. Irusta, S. J. Hoffman, M. P. Schiatti, G. A. Melendi, M. F. Delgado, F. R. Laham, B. Thumar, R. M. Hendry, J. A. Melero, R. A. Karron, P. L. Collins, and S. R. Kleeberger. 2005. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. USA 102:8996-9001.
33. Pringle, C. R., and R. P. Eglin. 1986. Murine pneumonia virus: seroepidemiological evidence of widespread human infection. J. Gen. Virol. 67:975-982.
34. Randhawa, J. S., P. Chambers, C. R. Pringle, and A. J. Easton. 1995. Nucleotide sequences of the genes encoding the putative attachment glycoprotein (G) of mouse and tissue culture-passaged strains of pneumonia virus of mice. Virology 207:240-245.
35. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
36. Richter, C. B., J. E. Thigpen, C. S. Richter, and J. M. Mackenzie, Jr. 1988. Fatal pneumonia with terminal emaciation in nude mice caused by pneumonia virus of mice. Lab. Anim. Sci. 38:255-261.
37. Schlender, J., B. Bossert, U. Buchholz, and K. K. Conzelmann. 2000. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J. Virol. 74:8234-8242.
38. Schmidt, U., J. Beyer, U. Polster, L. J. Gershwin, and U. J. Buchholz. 2002. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV. J. Virol. 76:12355-12359.
39. Spann, K. M., K. C. Tran, B. Chi, R. L. Rabin, and P. L. Collins. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J. Virol. 78:4363-4369. (Erratum, 78:6705.)
40. Techaarpornkul, S., N. Barretto, and M. E. Peeples. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75:6825-6834.
41. Teng, M. N., S. S. Whitehead, and P. L. Collins. 2001. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289:283-296.
42. Thorpe, L. C., and A. J. Easton. 2005. Genome sequence of the non-pathogenic strain 15 of pneumonia virus of mice and comparison with the genome of the pathogenic strain J3666. J. Gen. Virol. 86:159-169.
43. Valarcher, J. F., J. Furze, S. Wyld, R. Cook, K. K. Conzelmann, and G. Taylor. 2003. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J. Virol. 77:8426-8439.
44. Weir, E. C., D. G. Biwnstein, A. L. Smith, and E. A. Johnson. 1988. Respiratory disease and wasting in athymic mice infected with pneumonia virus of mice. Lab. Anim. Sci. 38:133-137.
45. Whitehead, S. S., A. Bukreyev, M. N. Teng, C. Y. Firestone, M. St Claire, W. R. Elkins, P. L. Collins, and B. R. Murphy. 1999. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J. Virol. 73:3438-3442.
46. Wilson, R. L., S. M. Fuentes, P. Wang, E. C. Taddeo, A. Klatt, A. J. Henderson, and B. He. 2006. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80:1700-1709.
47. Zhang, L., M. E. Peeples, R. C. Boucher, P. L. Collins, and R. J. Pickles. 2002. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J. Virol. 76:5654-5666.